Skip to main content
logo
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Dec 2, 2025 - SONN was delisted (reason: merged into PURR)
1.260
-1.840 (-59.35%)
Inactive · Last trade price on Dec 2, 2025

Revenue by Product

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202014 - 2018
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Dec '19 2014 - 2018
Immuno-oncology Treatments
18.63K
Log In
Log In
Log In
Log In
Upgrade
Immuno-oncology Treatments Growth
-87.40%
Log In
Log In
Log In
Log In
Upgrade
Restaurant
-
Log In
Log In
Log In
Log In
Upgrade
Franchise
-
Log In
Log In
Log In
Log In
Upgrade
Gaming
-
Log In
Log In
Log In
Log In
Upgrade
Management Fee Income
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202014 - 2018
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Dec '19 2014 - 2018
United States
18.63K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-87.40%
Log In
Log In
Log In
Log In
Upgrade
United States and United Kingdom
-
Log In
Log In
Log In
Log In
Upgrade